Gyre Therapeutics (GYRE) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 409.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 409.47% |
| Dec 31, 2025 | 710.76% |
| Sep 30, 2025 | 383.97% |
| Jun 30, 2025 | 5,562.50% |
| Mar 31, 2025 | 4,509.09% |
| Dec 31, 2024 | -91.76% |
| Sep 30, 2024 | 141.84% |
| Jun 30, 2024 | -82.02% |
| Mar 31, 2024 | -94.76% |
| Dec 31, 2023 | -43.95% |
| Sep 30, 2023 | -56.25% |
| Jun 30, 2023 | -74.28% |
| Mar 31, 2023 | -59.22% |
| Dec 31, 2022 | 1,698.10% |
| Sep 30, 2022 | -68.58% |
| Jun 30, 2022 | -64.80% |
| Mar 31, 2022 | -49.81% |
| Dec 31, 2021 | -25.76% |
| Sep 30, 2021 | -33.24% |
| Jun 30, 2021 | 17.87% |
| Mar 31, 2021 | 27.45% |
| Dec 31, 2020 | 37.11% |
| Sep 30, 2020 | 33.33% |
| Jun 30, 2020 | -7.64% |
| Mar 31, 2020 | -2.90% |
| Dec 31, 2019 | -9.32% |
| Sep 30, 2019 | 14.10% |
| Jun 30, 2019 | 63.88% |
| Mar 31, 2019 | 36.80% |
| Dec 31, 2018 | 141.04% |
| Sep 30, 2018 | 116.00% |
| Jun 30, 2018 | 396.40% |
| Mar 31, 2018 | 405.00% |
| Dec 31, 2017 | 136.15% |
| Sep 30, 2017 | 72.87% |
| Jun 30, 2017 | -32.73% |
| Mar 31, 2017 | -21.57% |
| Dec 31, 2016 | -31.94% |
| Sep 30, 2016 | 261.54% |
| Jun 30, 2016 | 302.44% |
| Mar 31, 2016 | 247.73% |
| Dec 31, 2015 | 247.27% |
| Sep 30, 2015 | -7.14% |
| Jun 30, 2015 | -91.16% |
| Mar 31, 2015 | -94.67% |
| Dec 31, 2014 | 101.43% |
| Sep 30, 2014 | -91.79% |
| Jun 30, 2014 | -29.16% |
| Mar 31, 2014 | -48.88% |
| Dec 31, 2013 | -380.04% |
| Sep 30, 2013 | -23.28% |
| Jun 30, 2013 | -68.31% |
| Mar 31, 2013 | -15.76% |
| Dec 31, 2012 | -31.17% |
| Sep 30, 2012 | -1.77% |
| Jun 30, 2012 | 119.19% |
| Mar 31, 2012 | -11.42% |
| Dec 31, 2011 | 62.24% |
| Sep 30, 2011 | 45.03% |
| Jun 30, 2011 | 91.28% |